C. Kuo

Machine learning algorithms to estimate 10-Year survival in patients with bone metastases due to prostate cancer: toward a disease-specific survival estimation tool

J. Forsberg, R. Wedin, Yongmei Chen, 2022, BMC cancer.

Proteomic Tissue-Based Classifier for Early Prediction of Prostate Cancer Progression

Thomas L. Fillmore, Richard D. Smith, S. Srivastava, 2020, Cancers.

Analysis of PMEPA1 Isoforms (a and b) as Selective Inhibitors of Androgen and TGF-β Signaling Reveals Distinct Biological and Prognostic Features in Prostate Cancer

Z. Szallasi, S. Srivastava, Hua Li, 2019, Cancers.

A prospective analysis of health-related quality of life in intermediate and high-risk prostate cancer patients managed with intensity modulated radiation therapy, with vs. without hormonal therapy.

K. Badiozamani, T. Brand, C. Porter, 2020, Urologic oncology.

Timing of Androgen Deprivation Treatment for Men with Biochemical Recurrent Prostate Cancer in the Context of Novel Therapies

B. Trock, Jiji Jiang, M. Eisenberger, 2021, The Journal of urology.

Alkaline Phosphatase Kinetics Predict Metastasis among Prostate Cancer Patients Who Experience Relapse following Radical Prostatectomy

A. Metwalli, Yongmei Chen, L. Hurwitz, 2018, BioMed research international.

Increased frequency of CHD1 deletions in prostate cancers of African American men is associated with distinct homologous recombination deficiency associated DNA aberration profiles

Z. Szallasi, I. Csabai, G. Klus, 2021, medRxiv.